BRITTANY F HATTIER

Allopathic & Osteopathic Physicians|Family Medicine COVINGTON, LA NPI 1336587138

General Payments — all program years on this page

$5,669.05

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 357
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $359.80 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $359.8021

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $235.2418
2019 $54.104
2020 $126.608
2021 $1,135.4874
2022 $1,709.37108
2023 $2,048.46124
2024 $359.8021

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086188720 Bayer Healthcare Pharmaceuticals Inc. $17.45 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086203503 Bayer Healthcare Pharmaceuticals Inc. $18.11 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096874966 Novo Nordisk Inc $19.04 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096953127 Novo Nordisk Inc $21.50 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097093398 Novo Nordisk Inc $16.76 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097141757 Novo Nordisk Inc $13.94 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103891711 ABBVIE INC. $14.49 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103891713 ABBVIE INC. $13.82 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116012057 GlaxoSmithKline, LLC. $16.60 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116045488 GlaxoSmithKline, LLC. $22.05 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116245725 GlaxoSmithKline, LLC. $18.70 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116496232 GlaxoSmithKline, LLC. $17.33 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116663925 GlaxoSmithKline, LLC. $14.98 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124996843 Abbott Laboratories $23.53 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136028472 Lilly USA, LLC $15.98 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136080219 Lilly USA, LLC $16.76 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136080221 Lilly USA, LLC $18.68 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137572906 Takeda Pharmaceuticals U.S.A., Inc. $14.95 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137572910 Takeda Pharmaceuticals U.S.A., Inc. $15.44 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137572914 Takeda Pharmaceuticals U.S.A., Inc. $14.95 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153708371 Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.74 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.